Characteristics and Distribution of Scholarship Donations From Pharmaceutical Companies to Japanese Healthcare Institutions in ۲۰۱۷: A Cross-sectional Analysis
سال انتشار: 1402
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 74
فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_HPM-12-0_069
تاریخ نمایه سازی: 17 مرداد 1403
چکیده مقاله:
Background Financial relationships between healthcare institutions and pharmaceutical companies can lead to conflicts of interest (COIs), potentially compromising patients’ care. In Japan, scholarship donations, unique type of payments made to healthcare institutions and their subunits by pharmaceutical industries without restricting their use including non-educational or research purpose, may often have implicit promotional purposes. However, detailed information about these payments remains scarce.Methods This study employed a cross-sectional design to analyse the extent and distribution of all scholarship donations made by all ۷۳ pharmaceutical companies belonging to the Japan Pharmaceutical Manufacturers Association (JPMA) to healthcare institutions in ۲۰۱۷. Data were obtained from publicly available sources from the companies, and the totalnumber of payments, their distributions across various institutions and specialties were analysed.Results A total of ۲۷ ۰۰۷ payment contracts amounting to ۱۷۸ ۷۰۳ ۷۲۱ in scholarship donations were made to ۴۸۳۹ specific departments and laboratories at ۲۵۱ different institutions by ۶۷ pharmaceutical companies. National universities received ۵۰.۸% of total payments. All universities setting medical school in Japan received one or more payments. Domestic pharmaceutical companies contributed to ۱۳۷ ۷۹۷ ۳۰۲ (۷۷.۱%) in total. Clinical medicine departments received ۸۹.۶% (۱۶۰ ۱۱۳ ۱۴۷) with ۶.۲% (۱۱ ۰۱۱ ۹۴۶) and ۲.۰% (۳ ۶۰۰ ۴۵۶) allocated to basic medicine and social medicine specialties, respectively.Conclusion This study provided a comprehensive overview of scholarship donations from pharmaceutical companies to healthcare institutions in Japan, revealing significant financial support primarily directed to national universities and clinical medicine departments. Japanese policy-makers should consider implementing regulations that promote transparency and mitigate potential COIs arising from scholarship donations, which may be useful in other countries with similar schemes.
کلیدواژه ها:
Transparency ، Japan ، Pharmaceutical Payment ، Non-research Payment ، Institutional Conflicts of Interest ، Health Policy
نویسندگان
Anju Murayama
Tohoku University School of Medicine, Sendai, Japan
Sae Kamamoto
Medical Governance Research Institute, Tokyo, Japan
Hiroaki Saito
Department of Internal Medicine, Soma Central Hospital, Soma, Japan
Erika Yamashita
Medical Governance Research Institute, Tokyo, Japan
Yosuke Suzuki
Medical Governance Research Institute, Tokyo, Japan
Tetsuya Tanimoto
Department of Internal Medicine, Navitas Clinic Kawasaki, Kawasaki, Japan
Piotr Ozieranski
Department of Social and Policy Sciences, University of Bath, Bath, UK
Akihiko Ozaki
Department of Breast and Thyroid Surgery, Jyoban Hospital of Tokiwa Foundation, Iwaki, Japan
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :